Gufic BioSciences announced that the Board of Directors of the Company at its meeting held on 29 May 2024, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Gufic BioSciences rose 10.71% to Rs 20.05 crore in the quarter ended March 2024 as against Rs 18.11 crore during the previous quarter ended March 2023. Sales rose 12.68% to Rs 194.99 crore in the quarter ended March 2024 as against Rs 173.04 crore during the previous quarter ended March 2023.For the full year,net profit rose 8.08% to Rs 86.14 crore in the year ended March 2024 as against Rs 79.70 crore during the previous year ended March 2023. Sales rose 16.80% to Rs 806.67 crore in the year ended March 2024 as against Rs 690.62 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales194.99173.04 13 806.67690.62 17 OPM %17.5518.59 -18.0819.50 - PBDT31.4629.86 5 132.70129.00 3 PBT27.1223.94 13 115.68106.72 8 NP20.0518.11 11 86.1479.70 8 Powered by Capital Market - Live News

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 29 May 2024Powered by Capital Market - Live News

Gufic BioSciences announced the sad demise of Shrirang Vaidya (DIN: 03618800), Independent Director of the Company on 01 April 2024. Powered by Capital Market - Live News

Net profit of Gufic BioSciences rose 9.44% to Rs 22.26 crore in the quarter ended December 2023 as against Rs 20.34 crore during the previous quarter ended December 2022. Sales rose 13.70% to Rs 201.78 crore in the quarter ended December 2023 as against Rs 177.47 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales201.78177.47 14 OPM %18.0719.43 - PBDT33.7032.89 2 PBT29.5627.25 8 NP22.2620.34 9 Powered by Capital Market - Live News